InDevR ampliPHOX colormetric detection technology in beta site-testing

InDevR, developer of advanced life science products, announced that its ampliPHOX Colorimetric Detection Technology is being beta site-tested in anticipation of an upcoming product launch. The original intellectual property was licensed from the University of Colorado at Boulder.

For second year in a row, One-quarter of Fairfield and Woods attorneys named to 2010 Super Lawyer list

Denver – Fairfield and Woods, P.C., a mid-size, full-service law firm, announced today that 11 of their lawyers were named to the Colorado Super Lawyers List. This group puts one-quarter of the firm’s attorneys on this prestigious list, and represents all areas of the firm’s full-service practice, including both established directors and new rising stars.

InVitria Optimizes Hybridoma Cell Culture with new product ZapHybridoma

Fort Collins – InVitria’s launch of Zap-Hybridoma provides a powerful solution for hybridoma cell culture. Zap–Hybridoma was created to improve monoclonal antibody productivity and deliver easier purification of the target product.

CaridianBCT Receives 510(k) Clearance on Latest Version of Trima Accel Automated Blood Collection System

LAKEWOOD – CaridianBCT, a leading global provider of technology, products and services in automated blood collections, therapeutic apheresis and cell therapy systems, whole blood processes and pathogen reduction technologies announced it has received 510(k) clearance for the Trima Accel® Automated Blood Collection System Version 6.0—providing increased efficiencies and streamlined operations to blood centers.

Hepquant Licenses University Of Colorado Test To Assess Chronic Liver Disease

AURORA – The University of Colorado and HepQuant, LLC, a Colorado-based company, have completed a licensing agreement allowing HepQuant to further develop a CU diagnostic technology to assess chronic liver disease.

Get the information you need on today’s newest drugs with this just–released annual report — it’s free.

Thomson Reuters is pleased to announce the release of our popular, comprehensive and annual review of new drugs on the market: The Year’s New Drugs & Biologics – 2009.

RMI² Launches New Entrepreneurship Program

Fort Collins – This spring the Rocky Mountain Innovation Initiative, or RMI², will launch a program designed to spur the formation of new entrepreneurial ventures in the clean energy, bioscience and technology industries. The program, called FastTrac® TechVenture™ was developed by the Ewing Marion Kauffman Foundation, which is partnering with RMI² in the program launch.

Dr. Jeanne Novak to be a panel member at the Institute of Medicine National Academy in Washington, DC

BOULDER – Dr. Jeanne Novak, CEO and President of CBR International Corp.® will be a panelist at the Institute of Medicine for discussion of accelerated approvals, “Opportunities for Accelerating Approval of Medical Countermeasures: Evolving the Regulatory Framework.”

Gov. honors OPX, Renewable Energy

DENVER – OPX Biotechnologies Inc. and Renewable Energy Systems Americas Inc. were presented Governor's Excellence in Renewable Energy awards by Gov. Bill Ritter Tuesday at the state capital.

UC Denver plans bioengineering department

The University of Colorado Denver plans to launch a bioengineering department.

OPX ahead of schedule on bioacrylic

BOULDER – OPX Biotechnologies Inc. in Boulder, a renewable biochemical and biofuel company, is progressing faster than planned in developing a commercial process for producing bioacrylic, a substitute for petroleum-based acrylic.

Baxa Corporation to Sponsor Customer-Requested DoseEdge™ Product Demonstrations Following Successful ASHP Midyear Clinical Meeting

Englewood – a leading developer of medical device technology for the safe handling, preparation, packaging and administration of fluid medications – announces a new road show program featuring their leading-edge dose management software, DoseEdge. Following Baxa Corporation’s highly regarded presentation at the 2009 American Society of Health-System Pharmacists Midyear Clinical Meeting in December, these programs allow customers who were unable to attend the Las Vegas meeting the opportunity to experience DoseEdge first-hand.

Scout Investor Relations Signs miRagen Therapeutics as New Client

BOULDER – Scout Investor Relations, a firm that provides investor relations and corporate communications consulting to publicly-traded and private companies, announced today that miRagen Therapeutics has retained Scout to provide ongoing investor relations and corporate communications support to the company.

Array's revenue up, loss narrows

BOULDER – Array Biopharma Inc. (Nasdaq: ARRY) raised its revenue and narrowed its loss during its fiscal 2010 second quarter, ending Dec. 31.

The Colorado Institute for Drug, Device and Diagnostic Development Launches with a Statewide “Call for Proposals”

Aurora – The Colorado Institute for Drug, Device and Diagnostic Development (CID4) officially launches this month with a statewide “Call for Proposals” from Colorado life science technologies in need of funding and active management. The announcement is made by Kevin M. Smith, CID4 Executive Vice President/COO and spokesperson, who says “CID4 is a private, not-for-profit entity, formed in 2009 to bridge the gap between basic research and successful product commercialization, thereby creating more Colorado jobs in the life science industry.”

National Jewish’s plan helps weather recession’s effects

Denver’s National Jewish Health is bucking national trends by expanding operations and increasing revenue thanks to a long-term strategic plan first implemented in 2007.

Deal temporarily saves Boulder jobs

BOULDER – A deal between two biopharmaceutical companies will keep some Boulder employees working here a little longer.

Array hires VP of clinical development

BOULDER – Array BioPharma Inc. has created a new job to oversee the Boulder-based biopharma's efforts in human clinical development of its drugs to treat cancer and inflammatory diseases.

InDevR pioneers tools for life sciences industry

BOULDER – Kathy Rowlen, the chemist, inventor and former professor who co-founded bioscience company InDevR Inc., speaks the language of business.

Amgen fourth-quarter profit rises 1%

The biotech firm's full-year revenue fell 2%. It projects that the release of denosumab and other new drugs will lead to modest revenue growth in 2010.

Clovis led Boulder Valley VC parade

BOULDER – Drug developer Clovis Oncology Inc. in Boulder led nine companies in the Boulder Valley that received $73.4 million in venture capital during fourth quarter 2009, according to the MoneyTree Report compiled by PricewaterhouseCoopers and the National Venture Association.

Gambro acquires CHF Solutions

Gambro AB’s U.S. division has acquired CHF Solutions Inc., the companies said Wednesday.

Biotech venture capital’s scarce, but not for GlobeImmune

Drug research being done by Louisville-based biotech GlobeImmune Inc. continues to attract investment at a time venture capital in the industry is scarce.

InDevR Virus Counter® to Streamline Vaccine Development

Boulder – InDevR, developer of advanced life science products, today announced the availability of the Virus Counter® for rapid virus quantification. The Virus Counter is a unique bio-analytical tool that enables scientists to measure virus particle concentration within minutes. Unlike conventional plaque titer assays, which take days to complete, the Virus Counter provides accurate virus quantification in less than 10 minutes. The unprecedented efficiency and accuracy of virus quantification with the Virus Counter is anticipated to dramatically accelerate vaccine and antiviral therapeutic research and development.

Covidien extends agreement to promote gastric band

Covidien plc has extended a deal with Allergan Inc. for the joint promotion of the latter company’s adjustable gastric band for bariatric surgery, called the Lap-Band System.

Amgen donates $1 million to CU

BOULDER – Amgen Inc. has donated $1 million to the University of Colorado at Boulder to help with the construction of the Jennie Smoly Caruthers Biotechnology Building.

HKH Pleased to Announce Ryan E. Warren as Member

We are both delighted and proud of Mr. Warren's contributions to our firm as Director of Construction Law as well as his commitment to the successes of our clients. As our newest member, Mr. Warren strengthens our capabilities even further and adds depth to our leadership.

MicroPhage set to sell test in Europe

LONGMONT – MicroPhage Inc. finished its blood-test study and plans to start shipping the test to Europe this month.

AmideBio Licenses Peptide Manufacturing Technology from University of Colorado

GOLDEN, – The University of Colorado and AmideBio, LLC have executed an exclusive license agreement allowing the Company to develop, manufacture and commercialize peptides based on the work of Michael Stowell, Ph.D., an associate professor of molecular, cellular and developmental biology at the University of Colorado at Boulder.

Microlife’s WatchWT MedGem® Device Will Be Used to Assess Metabolic Changes in the Biggest Loser™ Contestants

GOLDEN, – Microlife Medical Home Solutions, Inc. (MiMHS) announces The Biggest Loser medical staff will implement the MedGem indirect calorimeter to assess metabolic changes in program contestants. The MedGem handheld indirect calorimeter is an FDA-cleared, Class II, medical device that assesses metabolic rate by measuring a patient’s resting oxygen consumption.

Adrian Castro Joins Litigation Team At Fairfield and Woods, P.C.

Denver – Fairfield and Woods, P.C. announced today that Adrian Castro has joined our Litigation department as an associate.

Amgen resolves patent dispute with Roche

A U.S. District Court in Boston has set a permanent injunction prohibiting Roche from infringing on Amgen Inc.'s patents on recombinant erythropoietin (EPO), ending a five-year patent infringement dispute, Amgen — which has operations in Colorado — said Tuesday.

ARCA expands scope of beta-blocker

BROOMFIELD – ARCA biopharma Inc. in Broomfield has submitted a request for a special protocol assessment, or SPA, with the FDA for the design of a clinical trial to assess the safety and effectiveness of the biopharma's beta-blocker Gencaro.

Microlife Medical Home Solutions Launches Comprehensive Online Health Management Program; MiHealthLog™

Golden – Microlife Medical Home Solutions, Inc. (MiMHS) launched MiHealthLog web-application for consumers who are interested in better managing their health and wellness.

Pico-Tesla reports first seven patients enrolled in IRB-approved pilot study for treating type 2 diabetes with its proprietary magnetic (Magneceutical™) therapy

LITTLETON – Pico-Tesla, The Magneceutical™ Therapy Company,announced today that it has enrolled the first seven patients for a randomized, double-blind, placebo-controlled Pilot Study of persons who have type 2 diabetes, the most common form of diabetes. The Pilot Study seeks to determine whether the application of magnetic fields generated by the Company's patented Resonator™ system can be effective as an adjunctive therapy to oral medications in reducing hemoglobin A1c levels.

Online Video of InVitria’s Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance

Fort Collins – Scientists working with CHO cells can now access an informational online video featuring a presentation by Dr. Steve Pettit, InVitria’s Director of Cell Culture Product Development. Zap-CHO is a robust CHO cell supplement that maximizes CHO cell line performance and speeds-up cell line development processes. Zap-CHO is not a hydrolysate; it is an animal free, well defined and consistent recombinant CHO supplement.

Array BioPharma, Amgen reach deal on diabetes drug

Colorado research biotech Array BioPharma Inc. has reached a deal with industry giant Amgen Inc. that gives $60 million to Array and separately funds research jobs at the company.

Interim results good for Array drug

BOULDER – Array BioPharma Inc.'s breast-cancer fighting drug has received positive interim results during a phase 1 trial.

Small Business Commerce Association's Award Honors Howe Creative

SAN FRANCISCO – The Small Business Commerce Association (SBCA) is pleased to announce that HoweCreative has been selected fro the 2009 Best of Business Award in the Advertising category.

Baxa Features DoseEdge™ Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting

Englewood – Baxa Corporation is featuring its complete workflow management system, DoseEdge™, during this week’s ASHP Midyear Clinical Meeting (MCM). DoseEdge is a fully integrated system for improving patient safety and pharmacy efficiency through the management of IV and oral dose preparation activities. The technology fits easily into current pharmacy practice and techniques, while providing a framework for reducing medication errors and the management tools for just-in-time production and resource planning. The ASHP MCM is the largest gathering of pharmacists in the world and a great venue to demonstrate the capabilities of the DoseEdge system to the pharmacy industry.

MicroPhage obtains CE Mark to sell world's first rapid MRSA/MSSA test in Europe

LONGMONT – MicroPhage announced today that it has obtained its CE Mark to market in Europe the first of its instrument-free, rapid tests based on its patented Bacteriophage Amplification technology. The Company's initial commercial product is designed to rapidly identify Staphylococcus aureus ("staph") bacteria as well as determine methicillin resistance (MRSA) or susceptibility (MSSA) in suspected cases of bacteremia-bacteria in the blood-in as little as five hours. Today's standard of care for determining these types of infections takes up to three days for test-results, which can result in ineffective treatment, bacterial resistance, and death.

BiOptix Named a Top Innovator Winner

BiOptix is pleased to announce that it has been selected as a winner of the annual New England Venture Summit Top Innovator award by youngStartup Ventures. The list of privately held companies recognizes those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.

Patent issued for Allos Therapeutics' cancer drug Folotyn

Colorado biotech firm Allos Therapeutics Inc. said Monday that a patent has been issued for the use of its key product, the cancer drug Folotyn, to treat T-cell lymphoma.

Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned

Englewood – Baxa Corporation is sponsoring a professional presentation discussing what “culture of safety” means in today’s pharmacy environment. The Midday Symposium presentation, “Creating a Culture of Safety in Pharmacy,” features a panel of health-system professionals discussing their experiences with culture of safety, what it takes to build a culture of safety in pharmacy and the role of technology in enabling or inhibiting safe practice. The ACPE-accredited program takes place on Monday, December 7th at American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting at the Venetian Resort-Hotel in Las Vegas. Attendees to this free, two-hour presentation will also learn how automation can help their facility ensure patient safety.

Evergreen Research, Inc. Enters into a New Era with New Owners

Evergreen Research, Inc., a contract product development and manufacturing firm with a 21-year history has been purchased by fellow employees Gary Heath and David Mabe, two veterans of the medical device industry. Heath and Mabe believe the depth and breadth of the company’s capabilities will make Evergreen Research a dominant player in the Colorado medical device industry. Says Mabe, “This company is one of the best-kept secrets on the Front Range, and we look forward to sharing our expertise with others in the industry.” The new owners cite the company’s multiple strengths in engineering, manufacturing, and quality/regulatory, as well as the caliber of the company’s workforce, as their reasons for buying the company in a deal that closed November 13.